The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Smartphone apps for calculating insulin dose: a systematic assessment
Open accessAbstract
BACKGROUND: Medical apps are widely available, increasingly used by patients and clinicians, and are being actively promoted for use in routine care. However, there is little systematic evidence exploring possible risks associated with apps intended for patient use. Because self-medication errors are a recognized source of avoidable harm, apps that affect medication use, such as dose calculators, deserve particular scrutiny. We explored the accuracy and clinical suitability of apps for calculating medication doses, focusing on insulin calculators for patients with diabetes as a representative use for a prevalent long-term condition. METHODS: We performed a systematic assessment of all English-language rapid/short-acting insulin dose calculators available for iOS and Android. RESULTS: Searches identified 46 calculators that performed simple mathematical operations using planned carbohydrate intake and measured blood glucose. While 59% (n = 27/46) of apps included a clinical disclaimer, only 30% (n = 14/46) documented the calculation formula. 91% (n = 42/46) lacked numeric input validation, 59% (n = 27/46) allowed calculation when one or more values were missing, 48% (n = 22/46) used ambiguous terminology, 9% (n = 4/46) did not use adequate numeric precision and 4% (n = 2/46) did not store parameters faithfully. 67% (n = 31/46) of apps carried a risk of inappropriate output dose recommendation that either violated basic clinical assumptions (48%, n = 22/46) or did not match a stated formula (14%, n = 3/21) or correctly update in response to changing user inputs (37%, n = 17/46). Only one app, for iOS, was issue-free according to our criteria. No significant differences were observed in issue prevalence by payment model or platform. CONCLUSIONS: The majority of insulin dose calculator apps provide no protection against, and may actively contribute to, incorrect or inappropriate dose recommendations that put current users at risk of both catastrophic overdose and more subtle harms resulting from suboptimal glucose control. Healthcare professionals should exercise substantial caution in recommending unregulated dose calculators to patients and address app safety as part of self-management education. The prevalence of errors attributable to incorrect interpretation of medical principles underlines the importance of clinical input during app design. Systemic issues affecting the safety and suitability of higher-risk apps may require coordinated surveillance and action at national and international levels involving regulators, health agencies and app stores.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eysenbach, G., Powell, J., Kuss, O., & Sa, E.-R. (2002) · JAMA · doi:10.1001/jama.287.20.2691 · Cited by 1,871 · cited 1×
“Simple criterion-based approaches have been used to help consumers judge the quality of websites [43], and criteria have recently been proposed for apps that either rely on structured disclosures by developers addressing a number of generic quality domains [44], such as testing undertaken during development, or incorp…”
BackgroundDiagnostic Inaccuracy of Smartphone Applications for Melanoma Detection
Wolf, J. A., Moreau, J. F., Akilov, O., Patton, T., English, J. C., Ho, J., & Ferris, L. K. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.2382 · Cited by 393
Smartphone applications for pain management
Rosser, B. A., & Eccleston, C. (2011) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2011.101102 · Cited by 364 · cited 1×
“tion and disease tracking may not adhere to evidence-based practices [15-17], but are unlikely to be actively harmful.”
BackgroundMedical apps for smartphones: lack of evidence undermines quality and safety
Buijink, A. W. G., Visser, B. J., & Marshall, L. (2013) · Evidence Based Medicine · doi:10.1136/eb-2012-100885 · Cited by 303 · cited 1×
“evidence concerning effectiveness and safety [11-14].”
Weight loss—there is an app for that! But does it adhere to evidence-informed practices?
Breton, E. R., Fuemmeler, B. F., & Abroms, L. C. (2011) · Translational Behavioral Medicine · doi:10.1007/s13142-011-0076-5 · Cited by 276
A Systematic Review of Quality Assessment Methods for Smartphone Health Apps
BinDhim, N. F., Hawkey, A., & Trevena, L. (2015) · Telemedicine and e-Health · doi:10.1089/tmj.2014.0088 · Cited by 142
Research works printed but not linked: 34
- Seabrook H, Stromer J, Shevkenek C, Bharwani A, de Grood J, Ghali W. Medical applications: a database and characterization of apps in Apple iOS and Android platforms. BMC Res Notes. 2014;7:573. · DOI
- Digitas Health. mBook 2013 Edition - Marketing Mobile Health. 2013. http://m.2013.digitashealth.com/Mbook2013_web.pdf .
- Commission E. Green paper on mobile health (“mHealth”). Brussels: European Commission; 2014.
- Cortez NG, Cohen IG, Kesselheim AS. FDA regulation of mobile health technologies. N Engl J Med. 2014;371:372–9. · DOI · Paper page
- Yang YT, Silverman RD. Mobile health applications: the patchwork of legal and liability issues suggests strategies to improve oversight. Health Aff (Millwood). 2014;33:222–7. · DOI
- England NHS. Five year forward view. UK: HM Government; 2014.
- McCartney M. How do we know whether medical apps work? BMJ. 2013;346:f1811. · DOI
- Chomutare T, Fernandez-Luque L, Årsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2011;13:e65. · DOI · Paper page
- Abroms LC, Lee Westmaas J, Bontemps-Jones J, Ramani R, Mellerson J. A content analysis of popular smartphone apps for smoking cessation. Am J Prev Med. 2013;45:732–6. · DOI · Paper page
- Huckvale K, Car M, Morrison C, Car J. Apps for asthma self-management: a systematic assessment of content and tools. BMC Med. 2012;10:144. · DOI · Paper page
- Schachter M. The epidemiology of medication errors: how many, how serious? Br J Clin Pharmacol. 2009;67:621–3. · doi:10.1111/j.1365-2125.2009.03418.x
- Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–64. · DOI · Paper page
- Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–16. · DOI · Paper page
- Lamont T, Cousins D, Hillson R, Bischler A, Terblanche M. Safer administration of insulin: summary of a safety report from the National Patient Safety Agency. UK: National Patient Safety Agency; 2010.
- Sears K, Scobie A, MacKinnon NJ. Patient-related risk factors for self-reported medication errors in hospital and community settings in 8 countries. Can Pharm J (Ott). 2012;145:88–93. · doi:10.3821/145.2.cpj88
- Bierbrier R, Lo V, Wu RC. Evaluation of the accuracy of smartphone medical calculation apps. J Med Internet Res. 2014;16:e32. · DOI
- American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31:S61–78. · DOI
- Rees C. Recommendations for insulin dose calculator risk management. J Diabetes Sci Technol. 2014;8:142–9. · DOI
- DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325:746. · DOI · Paper page
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. · DOI · Paper page
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. · DOI · Paper page
- Shashaj B, Busetto E, Sulli N. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII). Diabet Med. 2008;25:1036–42. · DOI
- Gross TM, Kayne D, King A, Rother C, Juth S. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther. 2003;5:365–9. · DOI
- Spiller HA, Borys DJ, Ryan ML, Sawyer TS, Wilson BL. Unintentional therapeutic errors involving insulin in the ambulatory setting reported to poison centers. Ann Pharmacother. 2011;45:17–22. · doi:10.1345/aph.1p517
- Beuhler MC, Spiller HA, Aleguas A. Demographics and outcome of unintentional insulin overdoses managed by three poison centers. Clin Toxicol (Phila). 2013;51:789–93. · DOI
- Claydon-Platt K, Manias E, Dunning T. Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study. Diabetes Res Clin Pract. 2012;97:223–30. · DOI
- Reason J. Human error: models and management. BMJ. 2000;320:768–70. · DOI · Paper page
- Bailey SC, Brega AG, Crutchfield TM, Elasy T, Herr H, Kaphingst K, et al. Update on health literacy and diabetes. Diabetes Educ. 2014;40:581–604. · DOI · Paper page
- Albrecht UV, von Jan U, Jungnickel T, Pramann O. App-synopsis - standard reporting for medical apps. Stud Health Technol Inform. 2013;192:1154.
- Lewis TL. A systematic self-certification model for mobile medical apps. J Med Internet Res. 2013;15:e89. · DOI
- U.S. Food and Drug Administration. Mobile medical applications - guidance for industry and food and drug administration staff. Rockville, MD, USA: U.S: Department of Health and Human Services; 2013.
- Eng DS, Lee JM. The promise and peril of mobile health applications for diabetes and endocrinology. Pediatr Diabetes. 2013;14:231–8. · DOI · Paper page
- Charani E, Castro-Sanchez E, Moore L, Holmes A. Do smartphone applications in healthcare require a governance and legal framework? It depends on the application! BMC Med. 2014;12:29. · DOI
- Hill J, Powell P. The national healthcare crisis: is eHealth a key solution? Bus Horiz. 2009;52:265–77. · DOI
Cited by
O’Connor, S., Hanlon, P., O’Donnell, C. A., Garcia, S., Glanville, J., & Mair, F. S. (2016) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-016-0359-3 · Cited by 636
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Metadata
- Authors
- Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K.-S., & Car, J.
- Venue
- BMC Medicine
- Published
- 2015-05-06
- Volume
- 13
- Issue
- 1
- Pages
- 106-106
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W1554470992
- Cited by
- 202
- References
- 6
- FWCI
- 49.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smartphone apps for calculating insulin dose: a systematic assessment. https://app.cochat.ai/papers/10.1186/s12916-015-0314-7
- The paper
- Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K.-S., & Car, J. (2015). Smartphone apps for calculating insulin dose: a systematic assessment. BMC Medicine. https://doi.org/10.1186/s12916-015-0314-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.